Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $9.00B.
ENTERPRISE VALUE (EV)
$9.00B
Axsome Therapeutics, Inc.
Market Cap
$9.11B
Enterprise Value (EV)
$9.00B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | $9.11B | $9.00B |
| Bruker Corporation (BRKRP)vs › | $9.35B | $11.08B |
| Insulet Corp. (PODD)vs › | $9.39B | $9.81B |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.78B | $9.59B |
| Henry Schein, Inc. (HSIC)vs › | $9.60B | $13.25B |
| Caris Life Sciences, Inc. (CAI)vs › | $8.59B | $8.35B |
| Bruker Corporation (BRKR)vs › | $9.72B | $11.45B |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | $4.76B |
| Align Technology, Inc. (ALGN)vs › | $10.07B | $9.09B |
| The Ensign Group, Inc. (ENSG)vs › | $10.08B | $12.06B |
Market Cap
$9.11B
Total Debt
$213.91M
Cash
$322.93M
Enterprise Value
$9.00B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
